NCIA 2019 Cannabis Business Summit

Sessions Speakers Exhibitors Floor Plan Buzz

A Look Into the Future: An FDA Regulatory Framework for Hemp/CBD (Room Executive H)

NCIA has been leading a coalition of scientists, doctors, CBD and Hemp entrepreneurs, and FDA lawyers to inform and influence FDA rule-making on CBD. Public comments were submitted to FDA prior to the July 2, 2019 deadline. NCIA's Director of Public Policy, Andrew Kline, testified at FDA's public hearing on May 31, 2019. The panelists in this session lead the drafting and editing of our coalition's public comments and will discuss the questions asked by FDA, the answers provided by our coalit